Abordagem das poliglobulias: com referência à um caso clínico / Polyglobulia approach: with reference to a clinical case

José Alfreu Soares Júnior, Maria Izabel de Azevedo Ferreira, Vitor Lucas Bonfim Mendes

Abstract


A poliglobulia é uma condição frequentemente encontrada na prática clínica, cujas etiologias, nos últimos anos, aumentaram a tal ponto, que uma abordagem cautelosa é essencial para estabelecer o diagnóstico. O objetivo deste artigo é expor um caso clínico e fazer uma revisão do manejo das poliglobulias. Essa abordagem é relevante devido ao risco de eventos trombóticos pela hiperviscosidade sanguínea, e também pelo potencial risco de progressão para leucemia, especialmente em casos de Policitemia Vera.

 

 


Keywords


policitemia; contagem de células sanguíneas; policitemia vera.

References


Keohane C, McMullin MF, Harrison C. The diagnosis and management of erythrocytosis. BMJ Journals. 2013 Nov; 347: 1-6.

Grace L, Arcasoy MO. The clinical and laboratory evolution of the patient with erythrocytosis. Eur J Intern Med. 2015; 26 (5): 297–302.

Tefferi A, Schrier SL. Diagnostic approach to the patient with polycythemia. Up to Date Inc. 2010 Nov. [Acesso 18 novembro de 2019]. Disponível em: https://www.uptodate.com/contents/diagnostic-approach-to-the-patient-with-polycythemia?search=diagnostic-approach-tothe-patient-with-polycythemia&source=search_result&selectedTitle=1~150&usage_type=default&display_rank=1.

WHO. World Health Organization. Classification of diseases. [Acesso em 18 novembro de 2019]. Disponível em: https://www.who.int/classifications/icd/en/.

Diagnosis in primary care and referral pathway for patients with a raised haematocrit. Referral Guidelines - Polycythaemia. Oxford University Hospitals - Department of Clinical Haematology. 2012.

McMullin MF. Investigation and management of erythrocytosis. Curr Hematol Malig Rep. 2016;11(5): 342-347.

McMullin MFF, Mead AJ, Ali S, Carga C, Chen F, Ewing J, et al. A guideline for the management of specific situations in polycythaemia vera and secondary erythrocytosis: A British Society for Haematology Guideline. Br J Haematol. 2019;184(2):161-175.

McMullin MF, Harrison CN, Ali S, Carga C, Chen F, Ewing J, et al. A guideline for the diagnosis and management of polycythaemia vera. A British Society for Haematology Guideline [published correction appears in Br J Haematol]. Apr. 2019;184(2):176-191.

McMullin MF. Diagnostic workflow for hereditary erythrocytosis and thrombocytosis. Hematology Am Soc Hematol Educ Program. 2019; 2019(1): 391-396.

Macedo J, Costa E, Barbot J, Neto C. Policitemia vera: a propósito de um caso clínico. Nascer e Crescer. 2015; 24 (2): 83-87.

Tefferi A. Polycythemia Vera: a comprehensive review and clinical recommendations. Mayo Clinic Proceedings. 2003;78 (2): 174–194.

Bose P, Verstovsek S. Updates in the management of polycythemia vera and essential thrombocythemia. Ther Adv Hematol. Aug. 2019. [Acesso 06 novembro de 2019];10. Disponível em: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6719465/.

Ginzburg YZ, Feola M, Zimran E, Varkonyi J, Ganz T, Hoffman R. Dysregulated iron metabolism in polycythemia vera: etiology and consequence. Springer Nature. 2018.

Tefferi A, Rumi E, Finazzi G, et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia. 2013;27:1874–1881.

Grinfeld J. Prognostic models in the myeloproliferative neoplasms. Blood Rev. 2020; 42:100713.




DOI: https://doi.org/10.34117/bjdv7n10-198

Refbacks

  • There are currently no refbacks.